Search results
Corporate boards have never been more prepared to face down the anti-ESG backlash, new research...
Fortune· 5 days agoIn the past, corporate boards were not much involved in these issues. In 2018, for example, when NYU Stern Center for Sustainable Business (CSB) first assessed sustainability on Fortune 100 ...
Leverkusen the Soccer Team Is Famous. the City Not So Much
US News & World Report· 4 days agoAn often-overlooked, small German city dominated by the pharmaceuticals industry is making an unlikely case to be considered one of Europe's soccer capitals ...
Biocon Biologics Obtains U.S. FDA Approval for Biosimilar Aflibercept for Yesafili™. Enters U.S....
WTRF Wheeling· 5 days agoBiocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), today announced that the U.S. Food and Drug Administration ...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 4 days agoGlobal Antibiotics Market Projected to Reach $49.6 Billion by 2027 PR Newswire BOSTON, May 22, 2024 Global Antibiotics Market, as forecasted by BCC Research, to Grow at a Compound Annual Growth Rate (CAGR) of 4.2% Through 2027 BOSTON, May 22, 2024
AI Is Deciphering Your Corporate Trade Secrets
Forbes· 4 days agoIn the high-stakes world of corporate competition, trade secrets are the hidden gems that give companies their competitive edge. AI's ability to analyze, learn, and decipher ...
Puma Biotechnology (PBYI) Falls 38% in 3 Months: Here's Why
Zacks· 2 days agoSales of Puma Biotechnology's (PBYI) sole marketed drug, Nerlynx, have been declining in recent quarters. Stiff competition in the target market is also a woe.
Roche (RHHBY) Cancer Drug Gets Breakthrough Therapy Designation
Zacks via Yahoo Finance· 5 days agoRoche's (RHHBY) inavolisib gets Breakthrough Therapy Designation in the United States for advanced...
Roche Cancer Drug Gets Breakthrough Therapy Designation - LigandPharmaceuticals (NASDAQ:LGND), ANI ...
Benzinga· 4 days agoRoche (OTC: RHHBY) obtained a Breakthrough Therapy Designation for its investigational oral therapy...
Ferrante launches life science caucus
Gloucester Daily Times· 1 day agoA pair of lawmakers launched a Life Sciences Caucus this month, adding another layer of Beacon Hill lobbying for the biopharma industry that appears...
Sanofi partners with OpenAI: here's how it will mitigate AI risks | Invezz
Invezz· 5 days agoWorking with the AI company will help Sanofi “go to market faster with our drugs” and address the...
